Data as of Sep 21, 2026 · Based on 3,332,371 AI responses across 10,526 prompts · See how Parse measures this
Sonnerie VC is a New York–based pre-seed and seed venture capital firm that backs university spinouts in healthcare, life sciences, therapeutics, and medical devices, providing the first institutional capital and taking board and advisory roles to help founders build. The firm seeks early “signal” at the lab–clinician boundary, investing before rounds are obvious and focusing on therapeutics, medical devices, life sciences, diagnostics, and regulated health tech. Its three-move approach—Listen, Back, Build—sources opportunities, makes the first institutional check, and supports governance to grow a finding into a fundable company.
The market map · 5 of 100 labelled
Deep Tech Venture Capital Firms →
OSS CapitalPicked instead2 questions
Bessemer Venture PartnersPicked instead2 questions
Precursor VenturesPicked instead1 question
Fabrice GrindaPicked instead1 question
Hustle FundPicked instead1 questionNo contexts measured yet.
Excerpts where Sonnerie VC appeared in the AI's answer
Sonnerie VC — particularly relevant if you're at pre-seed; it explicitly describes board/advisory roles as active obligations
Excerpts where Sonnerie VC appeared in the AI's answer
Sonnerie VC is also interesting: it explicitly focuses on pre-seed/seed university spin-outs in therapeutics, medical devices, diagnostics, and life sciences
